ÂÜÀòÂÒÂ×

Steven Little is a Qrono co-founder and brings more than 20 years of expertise in immunoengineering. He received his doctorate from the Massachusetts Institute of Technology's prestigious Langer Lab and has gone on to found two pharmaceutical spinouts in addition to Qrono Inc. At the University of Pittsburgh, his research focuses on the development of drug products that mimic and change the body’s own signals during inflammation and healing. Dr. Little is the Chairman of the Department of Chemical and Petroleum Engineering and is the William Kepler Whiteford Endowed Professor in the Departments of Bioengineering, Immunology, and Ophthalmology.